Pyridyl reverse sulfonamides for HBV treatment
US10428041B2 · kind B2 · utility
0Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2018 |
| Grant date | Oct 1, 2019 |
| Priority date | — |
| Expiry date | Nov 14, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D231/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.